Literature DB >> 25134913

Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation.

Bin Lu1, Xueqin Sun, Yuxuan Chen, Qi Jin, Qin Liang, Shangqin Liu, Yamu Li, Yan Zhou, Wenxin Li, Zan Huang.   

Abstract

INTRODUCTION: Altered gene expression coincides with leukemia development and may affect distinct features of leukemic cells. PITHD1 was significantly downregulated in leukemia and upregulated upon PMA induction in K562 cells undergoing megakaryocyte differentiation. We aimed to study the function of PITHD1 in megakaryocyte differentiation.
MATERIALS AND METHODS: K562 cells and fetal liver cells were used for either overexpression or downregulation of PITHD1 by retroviral or lentiviral transduction. FACS was used to detect the expression of CD41 and CD42 to measure megakaryocyte differentiation in these cells. Western blot and quantitative RT-PCR were used to measure gene expression. Dual luciferase assay was used to detect promoter or internal ribosomal entry site (IRES) activity.
RESULTS: Ectopic expression of PITHD1 promoted megakaryocyte differentiation and increased RUNX1 expression while PITHD1 knockdown showed an opposite phenotype. Furthermore, PITHD1 efficiently induced endogenous RUNX1 expression and restored megakaryocyte differentiation suppressed by a dominant negative form of RUNX1. PITHD1 regulated RUNX1 expression at least through two distinct mechanisms: increasing transcription activity of proximal promoter and enhancing translation activity of an IRES element in exon 3. Finally, we confirmed the function of PITHD1 in regulating RUNX1 expression and megakaryopoiesis in mouse fetal liver cells. CONCLUSION AND SIGNIFICANCE: PITHD1 was a novel activator of IRES and enhanced RUNX1 expression that subsequently promoted megakaryocyte differentiation. Our findings shed light on understanding the mechanisms underlying megakaryopoiesis or leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25134913     DOI: 10.1007/s00018-014-1704-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Gene expression atlas for human embryogenesis.

Authors:  Hong Yi; Lu Xue; Ming-Xiong Guo; Jian Ma; Yan Zeng; Wei Wang; Jin-Yang Cai; Hai-Ming Hu; Hong-Bing Shu; Yun-Bo Shi; Wen-Xin Li
Journal:  FASEB J       Date:  2010-04-29       Impact factor: 5.191

2.  A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.

Authors:  A Jacquel; M Herrant; V Defamie; N Belhacene; P Colosetti; S Marchetti; L Legros; M Deckert; B Mari; J-P Cassuto; P Hofman; P Auberger
Journal:  Oncogene       Date:  2006-02-02       Impact factor: 9.867

3.  Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms.

Authors:  A Pozner; D Goldenberg; V Negreanu; S Y Le; O Elroy-Stein; D Levanon; Y Groner
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 4.  From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.

Authors:  Sai-Juan Chen; Guang-Biao Zhou; Xiao-Wei Zhang; Jian-Hua Mao; Hugues de Thé; Zhu Chen
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

5.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.

Authors:  A Hart; F Melet; P Grossfeld; K Chien; C Jones; A Tunnacliffe; R Favier; A Bernstein
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

Review 6.  Insights into the biology of IRES elements through riboproteomic approaches.

Authors:  Almudena Pacheco; Encarnacion Martinez-Salas
Journal:  J Biomed Biotechnol       Date:  2010-02-02

Review 7.  Acute promyelocytic leukemia: from highly fatal to highly curable.

Authors:  Zhen-Yi Wang; Zhu Chen
Journal:  Blood       Date:  2008-03-01       Impact factor: 22.113

8.  AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.

Authors:  Yusuke Satoh; Itaru Matsumura; Hirokazu Tanaka; Sachiko Ezoe; Kentaro Fukushima; Masahiro Tokunaga; Masato Yasumi; Hirohiko Shibayama; Masao Mizuki; Takumi Era; Tsukasa Okuda; Yuzuru Kanakura
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

9.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

10.  Novel function of the chromosome 7 open reading frame 41 gene to promote leukemic megakaryocyte differentiation by modulating TPA-induced signaling.

Authors:  X Sun; B Lu; B Hu; W Xiao; W Li; Z Huang
Journal:  Blood Cancer J       Date:  2014-03-28       Impact factor: 11.037

View more
  7 in total

1.  PITHD1 is a proteasome-interacting protein essential for male fertilization.

Authors:  Hiroyuki Kondo; Takafumi Matsumura; Mari Kaneko; Kenichi Inoue; Hidetaka Kosako; Masahito Ikawa; Yousuke Takahama; Izumi Ohigashi
Journal:  J Biol Chem       Date:  2020-01-08       Impact factor: 5.157

2.  DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.

Authors:  Y Hu; H Su; C Liu; Z Wang; L Huang; Q Wang; S Liu; S Chen; J Zhou; P Li; Z Chen; H Liu; G Qing
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

3.  ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia.

Authors:  Xueqin Sun; Bin Lu; Cuijuan Han; Wanlin Qiu; Qi Jin; Dengju Li; Qiubai Li; Qiong Yang; Qiang Wen; Puneet Opal; Ameet R Kini; John D Crispino; Zan Huang
Journal:  Blood Cancer J       Date:  2017-12-22       Impact factor: 11.037

4.  SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival.

Authors:  Hexiu Su; Juncheng Hu; Liang Huang; Yang Yang; Morgan Thenoz; Anna Kuchmiy; Yufeng Hu; Peng Li; Hui Feng; Yu Zhou; Tom Taghon; Pieter Van Vlierberghe; Guoliang Qing; Zhichao Chen; Hudan Liu
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

5.  SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.

Authors:  Joshua D Bernstock; Luca Peruzzotti-Jametti; Tommaso Leonardi; Nunzio Vicario; Daniel Ye; Yang-Ja Lee; Dragan Maric; Kory R Johnson; Yongshan Mou; Aletta Van Den Bosch; Mark Winterbone; Gregory K Friedman; Robin J M Franklin; John M Hallenbeck; Stefano Pluchino
Journal:  EBioMedicine       Date:  2019-03-21       Impact factor: 8.143

6.  Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.

Authors:  Weili Jia; Qianyun Yao; Yanfang Wang; Zhenzhen Mao; Tianchen Zhang; Jianhui Li; Ye Nie; Xinjun Lei; Wen Shi; Wenjie Song
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

7.  Novel function of FAXDC2 in megakaryopoiesis.

Authors:  Q Jin; Y Ren; M Wang; P K Suraneni; D Li; J D Crispino; J Fan; Z Huang
Journal:  Blood Cancer J       Date:  2016-09-30       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.